SFRP4 and atrial fibrillation: Thus, the compartment-specific expression of canonical Wnt inhibitors such as SFRP1, SFRP4, DKK1, and APCDD1L37–40 may be one of the mechanisms employed to modulate Wnt/β-catenin signaling in the AF.